Full Press Release Details
SOUTH PLAINFIELD, N.J. , Jan. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced the launch of the company's 2022 Talent Pipeline Program, a one-year, global initiative designed to provide recent college graduates with high-quality, real-world opportunities at work. Throughout this immersive program, participants receive benefits such as mentorship, job coaching, career counseling and leadership development training.
"We are proud that the Talent Pipeline Program has provided such rewarding experiences to both the Fellows of the Talent Pipeline Program as well as our PTC employees," said Stuart W. Peltz , Ph.D., Chief Executive Officer, PTC Therapeutics. "Because of its success, we are thrilled to continue this innovative program for a second year. We are excited to bring in a new group of young, talented people and have them join the PTC family and to provide them with a rich opportunity to utilize their education to learn and grow."
Fellow selection process, manager support and on-the-job activities are aligned with PTC's goal to attract, develop and retain the best and brightest talent. The 2022 application period will begin on Feb. 11, 2022 , and the program will commence in June 2022 .
About the Talent Pipeline Program The 2022 Talent Pipeline Program will include approximately 30 Fellows for a one-year program of work experience with a stipend. Some positions will require that participants to live near PTC's research or manufacturing sites in New Jersey and California , and other positions will be remote. Successful Fellows will receive a Certificate of Completion, a letter of reference and consideration for future positions at PTC. For more information on the Talent Pipeline Program, please visit https://www.ptcbio.com/careers/talent-pipeline-program-fellowship/ .
For More Information:
Investors: Kylie O'Keefe +1 (908) 300-0691 [email protected]
Media: Jeanine Clemente +1 (908) 912-9406 [email protected]
SOURCE PTC Therapeutics, Inc.